Sana Biotechnology, Inc. (SANA) insider trading.
In Q3 2026, insiders at Sana Biotechnology, Inc. reported 3 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 2
- Last filed
- 2026-08-27
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Patel Dhavalkumar Dhirajlal | Officer · EVP, Chief Scientific Officer | 2 | 0 | 0 |
| Bishop Hans Edgar | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-27 | Patel Dhavalkumar Dhirajlal | F (D) | 41,158 | $4.11 | 183,352 | Form 4 |
| 2026-08-26 | Patel Dhavalkumar Dhirajlal | M (A) | 125,000 | $0 | 224,510 | Form 4 |
| 2026-07-06 | Bishop Hans Edgar | A (A) | 6,297 | $0 | 5,854,800 | Form 4 |
Transaction codes in this quarter
Get SANA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1770121&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · SANA company page · Sana Biotechnology, Inc. on SEC.gov
Questions
Are insiders buying or selling Sana Biotechnology, Inc. (SANA)?
In Q3 2026, insiders at Sana Biotechnology, Inc. reported 3 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Sana Biotechnology, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/sana.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.